Lukas F. Mager
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 5%
- Surgery
- Infectious Diseases top 10%
- Co-authors
- Kathy D. McCoyNicola PettKirsty BrownMarco GalloIan A. LewisRyan A. GrovesRegula BurkhardMarkus B. Geuking
- Topics
- Gut microbiota and health (6 papers)IL-33, ST2, and ILC Pathways (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)
- Partner nations
- CanadaGermanySwitzerland
In The Last Decade
Lukas F. Mager
14 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 773
- Oncology 547
- Immunology 513
- Surgery 201
- Infectious Diseases 172
Countries citing papers authored by Lukas F. Mager
This map shows the geographic impact of Lukas F. Mager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas F. Mager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas F. Mager more than expected).
Fields of papers citing papers by Lukas F. Mager
This network shows the impact of papers produced by Lukas F. Mager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas F. Mager. The network helps show where Lukas F. Mager may publish in the future.
Co-authorship network of co-authors of Lukas F. Mager
This figure shows the co-authorship network connecting the top 25 collaborators of Lukas F. Mager. A scholar is included among the top collaborators of Lukas F. Mager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas F. Mager. Lukas F. Mager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 22 | |
| 7 | 8 | |
| 8 | Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapybreakdown → | 910 |
| 9 | 116 | |
| 10 | 24 | |
| 11 | 43 | |
| 12 | 178 | |
| 13 | 73 | |
| 14 | 80 | |
| 15 | 29 |
About Lukas F. Mager
Lukas F. Mager is a scholar working on Biotechnology, Immunology and Allergy and Toxicology, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gut microbiota and health (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Biological Psychiatry (67 citations), Immunology (513 citations) and Oncology (547 citations). Lukas F. Mager has collaborated with scholars based in Canada, Germany and Switzerland. Frequent co-authors include Kathy D. McCoy, Nicola Pett, Kirsty Brown, Marco Gallo, Ian A. Lewis, Ryan A. Groves, Regula Burkhard, Markus B. Geuking, Hena R. Ramay and John Stagg. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.